49
Participants
Start Date
July 31, 2007
Primary Completion Date
November 30, 2009
Study Completion Date
April 30, 2010
MEDI-534
Multiple doses of MEDI-534 or Placebo at 10\^4 TCID50
MEDI-534
Multiple doses of MEDI-534 or Placebo at 10 \^5 TCID50.
MEDI-534
Multiple doses of MEDI-534 or Placebo at 10\^6 TCID50.
Withrop University Hospital, Mineola
SUNY Upstate Medical University, Syracuse
United Medical Associates, Binghamton
Primary Physicians Research, Inc., Pittsburgh
University of Maryland, Baltimore, Baltimore
Advanced Pediatrics, Vienna
Virginia Commonwealth University, Richmond
Marshall University Joan C. Edwards School of Medicine, Huntington
West Virginia University Health Science Center, Morgantown
North Georgia Clinical Research Center, Dalton
Miami Children's Hospital, Miami
Pediatric Partners, Palm Beach Gardens
Vanderbilt University Medical Center, Nashville
St. Vincent Mercy Medical Center Mercy Children's Hospital, Toledo
University Hospitals case Medical Center, Cleveland
MetroHealth Medical Center, Cleveland
Cincinnati Children's Hospital Medical Center, Cincinnati
Sanford Children's Specialty Clinic, Sioux Falls
University Consultants in Allergy and Immunology, Chicago
Children's Memorial Hospital, Chicago
Craig A. Spiegel, MD, Bridgeton
Meridian Clinical Research, LLC, Omaha
Arkansas Pediatric Research Division, Conway
Arkansas Pediatric Clinic, Little Rock
University of Texas Health Science Center of Houston Medical School, Houston
THe Children's Hospital, Aurora
Copperview Medical Center, South Jordan
Bear Care Pediatrics, Ogden
Rockwood Clinic Research Center, Spokane
Tufts-New England Medical Center, Boston
Lead Sponsor
MedImmune LLC
INDUSTRY